Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and...

por Torres, Antoni, Blasi, Francesco, Dartois, Nathalie, Akova, Murat
Publicado 2015

Tigecycline Versus Levofloxacin in Hospitalized Patients With Community-Acquired Pneumonia: An Analysis of Risk Factors

por Dartois, Nathalie, Cooper, C Angel, Castaing, Nathalie, Gandjini, Hassan, Sarkozy, Denise
Publicado 2013

A Retrospective Study of the Clinical Burden of Hospitalized All-Cause and Pneumococcal Pneumonia in Canada

por McNeil, Shelly A., Qizilbash, Nawab, Ye, Jian, Gray, Sharon, Zanotti, Giovanni, Munson, Samantha, Dartois, Nathalie, Laferriere, Craig
Publicado 2016

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia

por Tanaseanu, Cristina, Milutinovic, Slobodan, Calistru, Petre I, Strausz, Janos, Zolubas, Marius, Chernyak, Valeriy, Dartois, Nathalie, Castaing, Nathalie, Gandjini, Hassan, Cooper, C Angel
Publicado 2009